Back to top
more

Cognizant Technology Solutions (CTSH)

(Real Time Quote from BATS)

$74.71 USD

74.71
228,576

+0.92 (1.25%)

Updated Jul 17, 2024 10:38 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (102 out of 250)

Industry: Business - Software Services

Better trading starts here.

Zacks News

Headquartered in Teaneck, NJ, Cognizant Technology Solutions Corporation is a leading professional services company. The company was spun off from Dun & Bradstreet in 1996 and went public in 1998. Cognizant’s services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services, and business process services. Cognizant reported revenues of $16.78 billion in 2019. Revenues from clients added during 2019, including those related to acquisitions were $234 million.

Cognizant (CTSH) Misses on Q1 Earnings, Cuts 2019 Guidance

Cognizant Technology Solutions (CTSH) first-quarter 2019 results hurt by sluggish performance of Financial Services and Healthcare segments.

Cognizant (CTSH) Q1 Earnings and Revenues Miss Estimates

Cognizant (CTSH) delivered earnings and revenue surprises of -11.65% and -1.39%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Cognizant (CTSH) This Earnings Season?

Cognizant's (CTSH) first-quarter 2019 results are likely to benefit from domain expertise and acquisitions that are adding new customers.

Analysts Estimate Cognizant (CTSH) to Report a Decline in Earnings: What to Look Out for

Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Value Investors Consider Cognizant Technology (CTSH)?

Cognizant Technology (CTSH) stock may be a good choice for value-oriented investors right now from multiple angles.

CTSH or TYL: Which Is the Better Value Stock Right Now?

CTSH vs. TYL: Which Stock Is the Better Value Option?

Madhura Bhattacharyya headshot

Outlook for Business-Software Services Stocks Appears Bright

The Zacks Business-Software Services industry is gaining traction from a strong demand environment for multi cloud-enabled software solutions.

Why Is Cognizant (CTSH) Down 0.9% Since Last Earnings Report?

Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cognizant Acquires Meritsoft, Strengthens SaaS Portfolio

Cognizant's (CTSH) acquisition of Meritsoft not only strengthens the former's software-as-a-Service (SaaS) portfolio but also expands its footprint among financial institutions.

Cognizant (CTSH) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Cognizant's (CTSH) fourth-quarter 2018 results benefit from growth across all four domains.

Cognizant (CTSH) Q4 Earnings and Revenues Top Estimates

Cognizant (CTSH) delivered earnings and revenue surprises of 7.62% and 0.37%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Cognizant (CTSH) Q4 Earnings: Is a Disappointment in Store?

Cognizant's (CTSH) fourth-quarter results are likely to be hurt by banking weakness despite gains from solid domain expertise and acquisitions that are adding new customers.

Cognizant (CTSH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cognizant (CTSH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Cognizant (CTSH) Keep the Earnings Surprise Streak Alive?

Cognizant (CTSH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Accenture Rides on Buyouts & Cloud, Pricing Pressure Rife

While acquisitions increase Accenture's (ACN) revenue opportunities along with business mix and profitability, stiff completion leads to pricing pressure.

Accenture Boosts Financial Services With Orbium Buyout

The acquisition is likely to boost Accenture's (ACN) Financial Services segment and enhance its global presence in terms of Avaloq execution.

Why Is Cognizant (CTSH) Up 2.5% Since Last Earnings Report?

Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Accenture Completes Kaplan Buyout, Boosts Nordics Presence

The acquisition of Kaplan is a part of Accenture (ACN) Interactive's bid to boost Nordics presence.

The Zacks Analyst Blog Highlights: Walmart, Cognizant, Vale, Church & Dwight and Ball

The Zacks Analyst Blog Highlights: Walmart, Cognizant, Vale, Church & Dwight and Ball

Mark Vickery headshot

Top Stock Reports for Walmart, Cognizant & Vale

Today's Research Daily features new research reports on 12 major stocks, including Walmart (WMT), Cognizant (CTSH) and Vale (VALE).

Cognizant (CTSH) Beats on Q3 Earnings, Revenues Increase Y/Y

Cognizant's (CTSH) third-quarter 2018 results benefit from growth across all four domains.

Cognizant (CTSH) Q3 Earnings Surpass Estimates

Cognizant (CTSH) delivered earnings and revenue surprises of 5.31% and -0.03%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Cognizant (CTSH) in Q3 Earnings?

Cognizant's (CTSH) third-quarter results are likely to benefit from domain expertise and acquisitions that are adding new customers.

Cognizant (CTSH) Q3 Earnings Preview: What to Expect

Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TransUnion Inks Deal to Buy Rubixis, Boosts Healthcare Suite

The deal to acquire Rubixis is expected to boost TransUnion (TRU) Healthcare's portfolio.